Price of HIV Prevention Drug Truvada
The House Oversight and Reform Committee convened a hearing to examine the high pricing of the HIV prevention drug Truvada. Daniel O’Day, th… read more
The House Oversight and Reform Committee convened a hearing to examine the high pricing of the HIV prevention drug Truvada. Daniel O’Day, the CEO of Gilead, the company that makes the drug, testified on the pricing scheme and why the price for the pill is higher in the U.S. than in other countries. He said two of the reasons are because these countries have different health care systems than the U.S., and the other is because the drug is considered a generic abroad. Others who testified included physicians and HIV/AIDS advocates. close
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and tap the screen to see the at the bottom of the player. Tap the to see a complete list of all Points of Interest - click on any moment in the list and the video will play.
Points of Interest
For quick viewing, C-SPAN provides Points of Interest markers for some events.
Click the play button and move your cursor over the video to see the . Click on the marker to see the description and watch.
You can also click the in the lower left of the video player to see a complete list of all Points of Interest from this program - click on any moment in the list and the video will play.
People in this video
-
Stephen Ezell Vice President Information Technology and Innovation Foundation->Global Innovation Policy
-
Tim Horn Director National Alliance of State and Territorial AIDS Directors->Medication Access and Pricing
-
Aaron Lord M.D. Physician and HIV/AIDS Advocate
Hosting Organization
Featured Clips from This Video
-
Representative Ocasio-Cortez Confronts Gilead CEO Over Truvada Pricing
New York Democratic Representative Alexandria Ocasio Cortez asks Giliead CEO Daniel O'Day why the HIV prevention drug, T…
- 2 minutes
- 2,614 views
Related Video
-
House Oversight and Reform Committee Hearing on Prescription Drug Prices
The House Oversight and Reform Committee held a hearing on prescription drug prices and their impact on patients. Four p…
-
Pharmaceutical Executives Testimony on Drug Pricing, Day 1
Bristol-Myers Squibb CEO Dr. Giovanni Caforio, Teva CEO Kare Schultz and former Celgene CEO Mark Alles testified on pres…
-
Pharmaceutical Executives Testimony on Drug Pricing, Day 2
Amgen CEO Robert Bradway, Novartis U.S. Country President Thomas Kendris, and Mallinckrodt Pharmaceuticals CEO Mark Trud…
-
Opioid Crisis Field Hearing
The House Oversight and Government Reform Committee held a field hearing at Johns Hopkins Hospital on the opioid crisis.…